Targeting fatty acid metabolism in cancer and endothelial cells

Ulrike Harjes1, Joanna Kalucka1, Peter Carmeliet1

  • 1Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, Department of Oncology, University of Leuven, Leuven B-3000, Belgium; Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB, Leuven B-3000, Belgium.

Insights

Endothelial cells (ECs) use fatty acid oxidation (FAO) for proliferation, offering new anti-cancer strategies. Targeting FAO in ECs may inhibit tumour angiogenesis more effectively than current therapies.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Angiogenesis

Background:

  • Tumour angiogenesis is a validated anti-cancer target.
  • VEGF pathway inhibition shows limited clinical efficacy.
  • Endothelial cell (EC) metabolism is crucial for angiogenesis.

Purpose of the Study:

  • To review and compare fatty acid (FA) utilization in ECs and tumour cells (TCs).
  • To highlight novel therapeutic opportunities targeting EC metabolism.

Main Methods:

  • Literature review of FA metabolism in ECs and TCs.
  • Comparison of metabolic pathways.

Main Results:

  • Glycolytic metabolism fuels EC angiogenesis.
  • Fatty acid oxidation (FAO) is essential for EC proliferation, providing nucleotides.
  • ECs uniquely utilize FAO for nucleotide synthesis.

Conclusions:

  • Targeting EC FAO presents a novel therapeutic strategy for anti-angiogenesis therapy.
  • Understanding FA utilization in ECs and TCs can inform future cancer treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K